engineered a theranostic agent (named CP‐bF@PEG) for high‐contrast cancer NIR‐II fluorescence imaging‐guided precision PTT/GT.[121] CP‐bF@PEG was composed of a NIR‐II‐absorbing CP (PTTBBT) and a NO donor (benzofuroxan) with pegylated Pluronic F127 coating. The gene discussed is CP; the disease is cancer.